TINA APONTE: Open Payments
NPI 1154660892 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 21 payments from 9 companies in 2025. Trend: 2023 $207 · 2024 $388 · 2025 $523
Food & beverage: $424Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $161 |
| Exeltis, USA Inc. | 6 | $133 |
| Biogen, Inc. | 3 | $67 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| CooperSurgical, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $18 |
| MILLICENT US INC | 1 | $17 |
Products named: SLYND, ZURZUVAE, Veozah, Mirena, GARDASIL 9, Paragard T 380A, INJECTAFER, FEMLYV.
Industry payments across FL — which companies pay providers there.
